Search Results - "HAMASAKI, Victor"

Chemotherapy in head and neck cancer by Hamasaki, Victor K, Vokes, Everett E

“…The role of chemotherapy in the management of patients with head and neck cancer continues to evolve. Single-agent methotrexate or cisplatin, or the…”
Get full text

Chemotherapy and combined modality therapy in head and neck cancer by Hamasaki, Victor K, Vokes, Everett E

“…Chemotherapy for head and neck cancer is being actively investigated. Trials of cisplatin, infusional fluorouracil, and other new agents highlight the need for…”
Get full text

High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival by Somlo, G, Doroshow, J H, Forman, S J, Odom-Maryon, T, Lee, J, Chow, W, Hamasaki, V, Leong, L, Morgan, Jr, R, Margolin, K, Raschko, J, Shibata, S, Tetef, M, Yen, Y, Simpson, J, Molina, A

“…To examine the predictive value of tumor- and treatment-specific prognostic indicators of relapse-free survival (RFS) and overall survival (OS) in patients…”
Get more information

Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies by MORGAN, Robert J, NEWMAN, Edward M, SOMLO, George, CARROLL, Mary, CHOW, Warren, TETEF, Merry, HAMASAKI, Victor, YUN YEN, DOROSHOW, James H, SOWERS, Lawrence, SCANLON, Kevin, HARRISON, Jonathan, AKMAN, Steven, LEONG, Lucille, MARGOLIN, Kim, NILAND, Joyce, RASCHKO, James

“…Azidothymidine (AZT, zidovudine) has been shown to reverse cisplatin resistance in cell culture. This phase I study was performed to determine the maximally…”
Get full text

A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A by RASCHKO, James W, SYNOLD, Timothy W, TETEF, Merry L, YUN YEN, TER VEER, Anna, DOROSHOW, James H, CHOW, Warren, COLUZZI, Paul, HAMASAKI, Victor, LEONG, Lucille A, MARGOLIN, Kim A, MORGAN, Robert J, SHIBATA, Stephen I, SOMLO, George

“…In recognition of the variety of available chemotherapeutic modulating agents and their potential to enhance the efficacy of platinum-based therapy, we…”
Get full text

Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity : Flow cytometric and pharmacokinetic analysis by MORGAN, R. J, NEWMAN, E. M, SHIBATA, S, HAMASAKI, V, CARROLL, M, VASILEV, S, AKMAN, S, COLUZZI, P, WAGMAN, L, LONGMATE, J, PAZ, B, YUN YEN, DOROSHOW, J. H, KLEVECZ, R, MCGONIGLE, K, MARGOLIN, K, RASCHKO, J, CHOW, W, SOMLO, G, LEONG, L, TETEF, M

“…In this Phase I study, the maximally tolerated doses (MTDs) of i.p. iododeoxyuridine (IdUrd) alone and in combination with i.v. calcium leucovorin (LV) were…”
Get full text

High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support by R J Morgan, Jr, J H Doroshow, K Venkataraman, K Chang, J Raschko, G Somlo, L Leong, M Tetef, S Shibata, V Hamasaki, K Margolin, S Forman, S Akman, P Coluzzi, C Ahn, L Weiss, U Gadgil, J Harrison

“…The purpose of this study was to determine the maximally tolerated dose of doxorubicin administered during two cycles of intensive chemotherapy with…”
Get full text

Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumors by NEWMAN, E. M, CARROLL, M, SHIBATA, S, SOMLO, G, TETEF, M, YEN, Y, AHN, C. W, DOROSHOW, J. H, AKMAN, S. A, CHOW, W, COLUZZI, P, HAMASAKI, V, LEONG, L. A, MARGOLIN, K. A, MORGAN, R. J, RASCHKO, J. W

“…A group of 18 patients with advanced cancer were entered on a phase I study of a 120-h continuous intravenous infusion of hydroxyurea. The dose of hydroxyurea…”
Get full text

Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial by Somlo, G, Doroshow, J H, Lev-Ran, A, Ahn, D C, Hwang, L, Raschko, J W, Forman, S J, Margolin, K A, Morgan, R J, Leong, L A

“…To evaluate the protective effect of low-dose dopamine given as continuous infusion in patients who undergo chemotherapy with the nephrotoxin cisplatin…”
Get more information

Interferons and other cytokines in head and neck cancer by HAMASAKI, V. K, VOKES, E. E

“…The use of cytokines in head and neck cancer is increasingly under investigation. Clinical trials have tested the interferons, interleukin-2 and other…”
Get full text

Fluorouracil and leucovorin in advanced breast cancer by Doroshow, J H, Margolin, K, Leong, L, Akman, S, Morgan, Jr, R, Raschko, J, Somlo, G, Hamasaki, V, Womack, E, Newman, E

Get more information

Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies by Somlo, George, Chow, Warren, Hamasaki, Victor, Leong, Lucille, Margolin, Kim, Morgan, Robert, Sniecinski, Irena, Frankel, Paul, Reardon, Debbie, Longmate, Jeff, Raschko, James, Shibata, Stephen, O'Donnell, Margaret, Smith, Eileen, Tetef, Merry, Forman, Stephen, Yen, Yun, Molina, Arturo, Doroshow, James H

“…We evaluated the feasibility of tandem-cycle high-dose chemotherapy (HDCT) with cisplatin, melphalan, and peripheral blood progenitor cells (PBPCs). Fifty…”
Get full text

Risk of infection following laparotomy for penetrating abdominal injury by Dellinger, E P, Oreskovich, M R, Wertz, M J, Hamasaki, V, Lennard, E S

“…We analyzed the occurrence of putative risk factors for postoperative infection in 338 patients who underwent emergency laparotomy for penetrating abdominal…”
Get more information